EarningsQ2 2019 Earnings Report

Outlook Therapeutics (41O) Q2 2019 Earnings Report

8 Followers

DE:41O Q2 2019 EPS Results

Actual EPS-€0.51

Consensus EPS―

Beat/Miss―

One Year Ago EPS-€2.25

Actual Revenue€563.62K

Expected Revenue―

Beat/Miss―

YoY Revenue Growth―

QuarterQ2 2019

Date05/15/2019

TimeTBA

Conference CallWednesday, May 15, 2019

DE:41O Upcoming Earnings

Outlook Therapeutics's next earnings date is estimated for December 18, 2026, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Dec 18, 2026	2026 (Q4)	-0.06 / -	-0.053	―
Aug 14, 2026	2026 (Q3)	-0.07 / -0.08	-0.387	79.55% (+0.31)
May 15, 2026	2026 (Q2)	-0.11 / -0.14	-0.352	60.00% (+0.21)
Feb 17, 2026	2026 (Q1)	-0.20 / -0.19	-0.782	75.28% (+0.59)
Dec 19, 2025	2025 (Q4)	-0.23 / -0.05	-0.774	93.18% (+0.72)
Aug 14, 2025	2025 (Q3)	-0.31 / -0.39	-0.73	46.99% (+0.34)
May 15, 2025	2025 (Q2)	-0.48 / -0.35	-1.363	74.19% (+1.01)
Feb 14, 2025	2025 (Q1)	-0.67 / -0.78	-0.703	-11.25% (-0.08)
Dec 27, 2024	2024 (Q4)	-0.71 / -0.77	-0.879	12.00% (+0.11)
Aug 14, 2024	2024 (Q3)	-0.91 / -0.73	-1.407	48.13% (+0.68)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed